Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

CUR

Neuralstem (CUR)

Neuralstem Inc

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CUR

1 2 3 4 5 6 7 8 9 10 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
19/03/2021	18h15	GlobeNewswire Inc.	NeuroRx Announces Dosing of First Patient with ZYESAMI™ in P2/3 Clinical Study for the Treatment of Moderate and Severe COV...	NASDAQ:CUR	Neuralstem Inc
02/09/2020	14h00	PR Newswire (US)	Letter from Seneca Biopharma's Executive Chairman	NASDAQ:CUR	Neuralstem Inc
27/05/2020	17h00	PR Newswire (US)	Seneca Biopharma Announces the Closing of its $5 Million Registered Direct Offering	NASDAQ:CUR	Neuralstem Inc
04/11/2019	22h18	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CUR	Neuralstem Inc
31/10/2019	16h00	PR Newswire (US)	Seneca Biopharma to Begin Trading Under New Ticker Symbol SNCA	NASDAQ:CUR	Neuralstem Inc
30/10/2019	12h00	PR Newswire (US)	Seneca Biopharma and QYuns Therapeutics Sign Term Sheet for Global Licensing of Novel Monoclonal Antibodies for Treating Auto...	NASDAQ:CUR	Neuralstem Inc
30/10/2019	11h22	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CUR	Neuralstem Inc
29/10/2019	04h24	PR Newswire (US)	Seneca Biopharma to Present at the 7th China Renaissance Healthcare and Life Sciences Leadership Summit	NASDAQ:CUR	Neuralstem Inc
28/10/2019	14h00	PR Newswire (US)	Neuralstem Becomes Seneca Biopharma	NASDAQ:CUR	Neuralstem Inc
12/10/2019	01h34	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:CUR	Neuralstem Inc
12/10/2019	01h32	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (3/a)	NASDAQ:CUR	Neuralstem Inc
12/10/2019	01h31	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:CUR	Neuralstem Inc
12/10/2019	01h28	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:CUR	Neuralstem Inc
12/10/2019	01h26	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:CUR	Neuralstem Inc
12/10/2019	01h24	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:CUR	Neuralstem Inc
03/10/2019	15h31	PR Newswire (US)	Neuralstem Announces Adjustment to Inducement Grant Under Nasdaq Listing Rule 5636(c)(4)	NASDAQ:CUR	Neuralstem Inc
24/09/2019	22h52	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CUR	Neuralstem Inc
24/09/2019	13h30	PR Newswire (US)	Neuralstem Announces Last Subject Enrolled in Phase 2 Clinical Trial Evaluating Human Neural Stem Cells in Chronic Stroke Pat...	NASDAQ:CUR	Neuralstem Inc
17/09/2019	23h00	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CUR	Neuralstem Inc
14/08/2019	20h32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CUR	Neuralstem Inc
14/08/2019	13h32	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:CUR	Neuralstem Inc
14/08/2019	13h30	PR Newswire (US)	Neuralstem Reports Second Quarter 2019 Fiscal Results	NASDAQ:CUR	Neuralstem Inc
09/08/2019	15h05	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:CUR	Neuralstem Inc
07/08/2019	15h01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CUR	Neuralstem Inc
07/08/2019	13h30	PR Newswire (US)	Neuralstem Announces Nasdaq Hearings Panel Grants Request For Continued Listing	NASDAQ:CUR	Neuralstem Inc
31/07/2019	13h30	PR Newswire (US)	Neuralstem Closes $7.5 Million Underwritten Public Offering	NASDAQ:CUR	Neuralstem Inc
29/07/2019	22h47	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)	NASDAQ:CUR	Neuralstem Inc
26/07/2019	12h01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:CUR	Neuralstem Inc
26/07/2019	04h40	PR Newswire (US)	Neuralstem Announces Pricing of $7.5 Million Underwritten Public Offering	NASDAQ:CUR	Neuralstem Inc
25/07/2019	12h05	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:CUR	Neuralstem Inc

Showing the most relevant articles for your search:NASDAQ:CUR

1 2 3 4 5 6 7 8 9 10 Next >>

Deutsche Lufthansa

Financial Select Sector

Energy Select Sector SPDR

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen